A recent study reports that disruption of tracheal basal cell homeostasis is the key cellular event driving lung squamous ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Helene Duhamel was recently diagnosed with non-small cell squamous cell lung cancer. Duhamel shares her thoughts on her ...

This includes the airways in your lungs. One clinical trial of Opdivo involved adults with squamous non-small cell lung cancer (NSCLC). Researchers found that people with squamous NSCLC who took ...

Clemo said. In 2022, the cause hit closer to home than she ever thought possible when her mom was diagnosed with stage four lung cancer. Clemo said since her mom has never smoked, the diagnosis ...

Wang and his collaborators developed cell lines derived from patients with small cell lung cancer. When BRDT was suppressed in lung cancer cells, it significantly slowed tumor progression and ...

An independent data monitoring committee has determined that the HARMONi-6 trial for the first-line treatment of advanced squamous non-small cell lung cancer (NSCLC) has met its primary endpoint ...

33 patients will need to undergo a diagnostic test because of presumed increased risk – such as a chest X-ray or low-dose CT scan – and about 40 per cent of all patients with lung cancer will ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...